Nutra Pharma, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), introduced Nyloxin OTC, an over-the-counter pain reliever, that will be marketed and sold through international distribution channels alongside the company’s prescription pain reliever, Nyloxin Rx.
The details can be read here.
No comments:
Post a Comment